Search Results 471-480 of 18229 for Hepatitis C

  1. National Epilepsy Reports Highlights Gaps and Stigmas - Mayo Clinic News Network

    Planning on Tanning? Lessons Shared from Transmission of Hepatitis C Infection to Patients. Related Articles. Neurosciences. (VIDEO) When valley fever spreads ...

  2. Mononucleosis: Can it recur? - Mayo Clinic

    Some causes of mono other than EBV are: Cytomegalovirus. Toxoplasmosis. HIV. Rubella. Hepatitis A, B or C. Adenovirus. Talk to your health ...

  3. Cladribine (oral route) - Mayo Clinic

    Hepatitis B or C or; Tuberculosis, latent—Use with caution. May make these infections active again. Infection (eg, bacterial, viral, parasitic, and fungal) ...

  4. Videos - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    Robert C. Huebert, M.D., and Jorge Rakela, M.D., of Mayo Clinic discuss the regenerative properties of the liver to help those with chronic liver disease.

  5. Nausea and vomiting - Mayo Clinic

    Hepatitis C: How common is sexual transmission? Hepatitis C: What happens in end-stage liver disease? Hidden Heart Attack · Hirschsprung's disease · Holiday ...

  6. Abacavir, lamivudine, and zidovudine (oral route) - Mayo Clinic

    Hepatitis C, history of or; Hyperlipidemia (high cholesterol or fats in the blood) or; Hypertension (high blood pressure) or; Myopathy (muscle weakness)—Use ...

  7. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Autoimmun...e hepatitis, Hepatocellular carcinoma, Fatty liver disease, Hepatic encephalopathy. Show more areas of focus for Blanca C.

  8. Liver Transplant - Conditions treated

    Acute hepatitis · Acute liver failure · Alcoholic hepatitis · Alpha-1-antitrypsin deficiency · Amyloidosis · Autoimmune hepatitis · Biliary atresia · Budd-Chiari ...

  9. Dolutegravir (oral route) - Mayo Clinic

    Hepatitis B or C, or history of—Use with caution. May make this condition worse. Infections—May decrease your body's ability to fight infection. Kidney ...

  10. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

    Participation eligibility · Inability to undergo a liver biopsy. · Hepatitis B surface antigen (HBsAg) positive. · Hepatitis C antibody (HCVAb) positive with the ...